CannonM, CaspiA, MoffittTE, HarringtonH, TaylorA, MurrayRM, PoultonR: Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: Results from a longitudinal birth cohort. Arch Gen Psychiatry, 59:449–456, 2002.
2.
Cross-Disorder Group of the Psychiatric Genomics Consortium: Identification of risk loci with shared effects on five major psychiatric disorders: A genome-wide analysis. Lancet, 381:1371–1379, 2013.
3.
de LacyN, KingBH: Revisiting the relationship between autism and schizophrenia: Toward an integrated neurobiology. Annu Rev Clin Psychol, 9:555–587, 2013.
HelferB, SamaraMT, HuhnM, KluppE, LeuchtC, ZhuY, EngelRR, LeuchtS: Efficacy and safety of antidepressants added to antipsychotics for schizophrenia: A systematic review and meta-analysis. Am J Psychiatry, 173:876–886, 2016.
6.
LiebermanJA, PerkinsD, BelgerA, ChakosM, JarskogF, BotevaK, GilmoreJ: The early stages of schizophrenia: Speculations on pathogenesis, pathophysiology, and therapeutic approaches. Biol Psychiatry, 50:884–897, 2001.
7.
MaynardTM, SikichL, LiebermanJA, LaMantiaAS: Neural development, cell-cell signaling, and the “two-hit” hypothesis of schizophrenia. Schizophr Bull, 27:457–476, 2001.
8.
McClellanJ, StockS, American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI): Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry, 52:976–990, 2013.
9.
McNeilTF, FishB, SchubertEW: Prospective study of pandysmaturation and adult mental disorder in high-risk and normal-risk offspring. J Psychiatr Res, 45:561–567, 2011.
10.
MoshevaM, MekoriE, KantorS, BergY, WeizmanA, GothelfD: Do antidepressants induce psychosis in children and adolescents? A naturalistic study in an ambulatory pediatric population. J Child Adolesc Psychopharmacol, 26:478–484, 2016.
11.
ProchaskaJO, VelicerWF, RossiJS, GoldsteinMG, MarcusBH, RakowskiW, FioreC, HarlowLL, ReddingCA, RosenbloomD, et al.: Stages of change and decisional balance for 12 problem behaviors. Health Psychol, 13:39–46, 1994.
12.
RapoportJ, ChavezA, GreensteinD, AddingtonA, GogtayN: Autism spectrum disorders and childhood-onset schizophrenia: Clinical and biological contributions to a relation revisited. J Am Acad Child Adolesc Psychiatry, 48:10–18, 2009.
13.
Stentebjerg-OlesenM, PagsbergAK, Fink-JensenA, CorrellCU, JeppesenP: Clinical characteristics and predictors of outcome of schizophrenia-spectrum psychosis in children and adolescents: A systematic review. J Child Adolesc Psychopharmacol, 26:410–427, 2016.
14.
SullivanS, RaiD, GoldingJ, ZammitS, SteerC: The association between autism spectrum disorder and psychotic experiences in the Avon longitudinal study of parents and children (ALSPAC) birth cohort. J Am Acad Child Adolesc Psychiatry, 52:806.e802–814.e802, 2013.
15.
SuzukiT: Which rating scales are regarded as ‘the standard’ in clinical trials for schizophrenia? A critical review. Psychopharmacol Bull, 44:18–31, 2011.